Craig C. Hopkinson - 23 Feb 2022 Form 4 Insider Report for Alkermes plc. (ALKS)

Role
EVP R&D, Chief Medical Officer
Signature
/s/ Stephanie Roche, attorney-in-fact for Craig C. Hopkinson
Issuer symbol
ALKS
Transactions as of
23 Feb 2022
Net transactions value
-$296,650
Form type
4
Filing time
24 Feb 2022, 16:34:41 UTC
Previous filing
23 Feb 2022
Next filing
05 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALKS Ordinary Shares Sale $296,650 -11,983 -40% $24.76 17,994 23 Feb 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 The price reported in Column 4 of Table I is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.58 to $25.03. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.